Health-care companies rose amid generally strong earnings.
Generics manufacturer Teva Pharmaceutical Industries rose slightly after it reported quarterly earnings and sales ahead of Wall Street targets. Gains were limited, however, as Chief Executive Officer Kare Schultz told the Wall Street Journal that there would be no "quick fix" to litigation on opioid drugs.
CVS Health shares surged after the drug-store chain boosted its profit projection, quelling worries about the growth outlook for drug-industry middlemen.
Write to Rob Curran at firstname.lastname@example.org